| |
Latest 10 SEC filings (by transaction date) for AKBA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 1/24 | Feb 29/24 | Dahan Michel | Direct Ownership | Common Stock | S - Open market or private sale | -8,661 | $1.58 |
Mar 1/24 | Feb 29/24 | Hadas Nicole R. | Direct Ownership | Common Stock | S - Open market or private sale | -5,974 | $1.58 |
Mar 1/24 | Feb 29/24 | Butler John P. | Direct Ownership | Common Stock | S - Open market or private sale | -46,570 | $1.58 |
Mar 1/24 | Feb 29/24 | Burke Steven Keith | Direct Ownership | Common Stock | S - Open market or private sale | -7,169 | $1.58 |
Feb 29/24 | Feb 27/24 | Hadas Nicole R. | Direct Ownership | Common Stock | S - Open market or private sale | -7,411 | $1.52 |
Feb 29/24 | Feb 27/24 | Dahan Michel | Direct Ownership | Common Stock | S - Open market or private sale | -10,744 | $1.52 |
Feb 29/24 | Feb 27/24 | Burke Steven Keith | Direct Ownership | Common Stock | S - Open market or private sale | -8,367 | $1.52 |
Feb 29/24 | Feb 27/24 | Butler John P. | Direct Ownership | Common Stock | S - Open market or private sale | -37,733 | $1.52 |
Feb 2/24 | Feb 1/24 | Butler John P. | Direct Ownership | Common Stock | S - Open market or private sale | -46,489 | $1.68 |
Feb 2/24 | Feb 1/24 | Burke Steven Keith | Direct Ownership | Common Stock | S - Open market or private sale | -24,311 | $1.68 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for AKBA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 9/24 | Aug 25/23 | Burke Steven Keith | Direct Ownership | Common Stock | S - Open market or private sale | -27,000 | $1.15 |
Mar 1/24 | Feb 29/24 | Dahan Michel | Direct Ownership | Common Stock | S - Open market or private sale | -8,661 | $1.58 |
Mar 1/24 | Feb 29/24 | Hadas Nicole R. | Direct Ownership | Common Stock | S - Open market or private sale | -5,974 | $1.58 |
Mar 1/24 | Feb 29/24 | Butler John P. | Direct Ownership | Common Stock | S - Open market or private sale | -46,570 | $1.58 |
Mar 1/24 | Feb 29/24 | Burke Steven Keith | Direct Ownership | Common Stock | S - Open market or private sale | -7,169 | $1.58 |
Feb 29/24 | Feb 27/24 | Hadas Nicole R. | Direct Ownership | Common Stock | S - Open market or private sale | -7,411 | $1.52 |
Feb 29/24 | Feb 27/24 | Dahan Michel | Direct Ownership | Common Stock | S - Open market or private sale | -10,744 | $1.52 |
Feb 29/24 | Feb 27/24 | Burke Steven Keith | Direct Ownership | Common Stock | S - Open market or private sale | -8,367 | $1.52 |
Feb 29/24 | Feb 27/24 | Butler John P. | Direct Ownership | Common Stock | S - Open market or private sale | -37,733 | $1.52 |
Feb 2/24 | Jan 31/24 | Grund Nicholas | Direct Ownership | Stock Option (Right to buy) | A - Grant, award or other under Rule 16b-3(d) | 454,950 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |